Investigating eye diseases in survivors of viral hemorrhagic fevers
Ophthalmic Disease and Laboratory Surveillance in a Viral Hemorrhagic Fever Zone
This study is looking at eye problems that some people might have after surviving Ebola, and it aims to find out how common these issues are and what causes them, so we can better help those affected.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10688132 on NIH RePORTER |
What this research studies
This research focuses on understanding the ocular complications that arise in survivors of viral hemorrhagic fevers, particularly those who have survived Ebola virus disease. The study aims to identify the prevalence of eye diseases such as uveitis among these survivors and to explore the underlying mechanisms that lead to vision impairment. By conducting clinical assessments and laboratory surveillance, the research seeks to improve the management and treatment of eye conditions linked to these infectious diseases. Patients may undergo eye examinations and provide samples for analysis to help advance knowledge in this critical area.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have survived Ebola virus disease and are experiencing ocular symptoms or complications.
Not a fit: Patients who have not been exposed to viral hemorrhagic fevers or do not have any ocular complications may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better diagnosis and treatment options for eye diseases in survivors of viral hemorrhagic fevers, ultimately improving their quality of life.
How similar studies have performed: Previous research has shown significant ocular complications in Ebola survivors, indicating that this area of study is both relevant and necessary for improving patient outcomes.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Shantha, Jessica — University of California, San Francisco
- Study coordinator: Shantha, Jessica
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.